Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Characterization of 22 Antituberculosis Drugs for Inhibitory Interaction Potential on Organic Anionic Transporter Polypeptide (OATP)-Mediated Uptake.
Parvez MM
,
Jung JA
,
Shin HJ
,
Kim DH
,
Shin JG
.
???displayArticle.abstract???
We investigated the inhibitory interaction potential of 22 currently marketed antituberculosis (TB) drugs on organic anion-transporting polypeptide 1B1 (OATP1B1)-, OATP2B1-, and OATP1B3-mediated uptake using in vitro Xenopus oocytes and HEK cells. Rifabutin, ethambutol, amoxicillin, linezolid, p-amino salicylic acid, and rifapentine exhibited mild to moderate inhibitory effects on OATP-mediated uptake of estrone-3 sulfate, estradiol 17β-d-glucuronide, and rosuvastatin. The 50% inhibitory concentration (IC50) values of rifabutin, amoxicillin, ethambutol, p-amino salicylic acid, and linezolid were 35.4, 36.2, 57.6, 72.6, and 65.9 μM, respectively, for uptake mediated by organic anionic transporter polypeptide 1B1 (OATP1B1) and 28.8, 28.9, 53.9, 31.5, and 61.0 μM, respectively, for uptake mediated by organic anionic transporter polypeptide 1B3 (OATP1B3). Streptomycin and linezolid showed greater inhibition of organic anionic transporter polypeptide 2B1 (OATP2B1)-mediated uptake, with IC50 values of 33.2 and 35.6 μM, respectively, along with mild inhibition of other drugs. Furthermore, rifabutin, amoxicillin, and rifapentine significantly inhibited OATP1B1-mediated rosuvastatin uptake, with IC50 values of 12.3, 13.0, and 11.0 μM, respectively, which showed a similar profile to estrone-3 sulfate uptake. The calculated R values ([I]u inlet,max/Ki, where [I]u inlet,max represents the maximum estimated inhibitor concentration inlet to the liver and Ki is the inhibition constant) as the drug-drug interaction (DDI) indexes of PAS, ethambutol, and amoxicillin were 26.1, 6.5, and 4.3 for OATP1B1 and 52.0, 8.0, and 4.6 for OATP1B3, and those for streptomycin, amikacin, and linezolid were 5.0, 4.2, and 4.4 for OATP2B1, respectively, suggesting a higher possibility of in vivo DDIs. This study is the first comprehensive report to show the novel inhibitory potential of 22 marketed anti-TB drugs on OATP-mediated uptake, providing evidence for future in vivo clinical DDI studies.
Amundsen,
Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin.
2010, Pubmed
Amundsen,
Cyclosporine A, but not tacrolimus, shows relevant inhibition of organic anion-transporting protein 1B1-mediated transport of atorvastatin.
2010,
Pubmed
Andrews,
Factors affecting the in-vitro activity of roxithromycin.
1987,
Pubmed
Bi,
In vitro evaluation of hepatic transporter-mediated clinical drug-drug interactions: hepatocyte model optimization and retrospective investigation.
2012,
Pubmed
Bolhuis,
Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients.
2013,
Pubmed
Boulanger,
Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis.
2009,
Pubmed
Burman,
Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.
2001,
Pubmed
Cabana,
Comparative pharmacokinetics of BB-K8 and kanamycin in dogs and humans.
1973,
Pubmed
Collier,
Two cases of ethambutol nephrotoxicity.
1976,
Pubmed
Cui,
Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6.
2001,
Pubmed
Dean,
The human ATP-binding cassette (ABC) transporter superfamily.
2001,
Pubmed
Dehghanyar,
Penetration of linezolid into soft tissues of healthy volunteers after single and multiple doses.
2005,
Pubmed
de Kock,
Pharmacokinetics of para-aminosalicylic acid in HIV-uninfected and HIV-coinfected tuberculosis patients receiving antiretroviral therapy, managed for multidrug-resistant and extensively drug-resistant tuberculosis.
2014,
Pubmed
Egelund,
Protein binding of rifapentine and its 25-desacetyl metabolite in patients with pulmonary tuberculosis.
2014,
Pubmed
Franco,
Bioequivalence study of two commercial amoxicillin suspension formulations in healthy human volunteers.
2014,
Pubmed
Fredriksson,
The solute carrier (SLC) complement of the human genome: phylogenetic classification reveals four major families.
2008,
Pubmed
García-Martín,
Acute interstitial nephritis induced by ethambutol.
1991,
Pubmed
Gebhart,
Decreased serum linezolid levels in a critically ill patient receiving concomitant linezolid and rifampin.
2007,
Pubmed
Gonzalez,
Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents.
2013,
Pubmed
Gordon,
Serum protein binding of the aminoglycoside antibiotics.
1972,
Pubmed
Grube,
Organic anion transporting polypeptide 2B1 is a high-affinity transporter for atorvastatin and is expressed in the human heart.
2006,
Pubmed
Gui,
Effect of pregnane X receptor ligands on transport mediated by human OATP1B1 and OATP1B3.
2008,
Pubmed
Hafner,
Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.
1998,
Pubmed
Hagenbuch,
Drug uptake systems in liver and kidney: a historic perspective.
2010,
Pubmed
Hirano,
Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the hepatic uptake of pitavastatin in humans.
2004,
Pubmed
Ho,
Drug and bile acid transporters in rosuvastatin hepatic uptake: function, expression, and pharmacogenetics.
2006,
Pubmed
Ho,
Transporters and drug therapy: implications for drug disposition and disease.
2005,
Pubmed
Holdiness,
Clinical pharmacokinetics of clofazimine. A review.
1989,
Pubmed
Ito,
Prediction of pharmacokinetic alterations caused by drug-drug interactions: metabolic interaction in the liver.
1998,
Pubmed
Izumi,
Investigation of the impact of substrate selection on in vitro organic anion transporting polypeptide 1B1 inhibition profiles for the prediction of drug-drug interactions.
2015,
Pubmed
Kajosaari,
Cyclosporine markedly raises the plasma concentrations of repaglinide.
2005,
Pubmed
Kobayashi,
Possible involvement of organic anion transporter 2 on the interaction of theophylline with erythromycin in the human liver.
2005,
Pubmed
,
Xenbase
Kopplow,
Human hepatobiliary transport of organic anions analyzed by quadruple-transfected cells.
2005,
Pubmed
Kullak-Ublick,
Regulation of organic anion and drug transporters of the sinusoidal membrane.
1999,
Pubmed
Laal,
Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
1987,
Pubmed
Lau,
effect of OATP1B transporter inhibition on the pharmacokinetics of atorvastatin in healthy volunteers.
2007,
Pubmed
Lee,
Kinetics of oral ethambutol in the normal subject.
1977,
Pubmed
Lemahieu,
Combined therapy with atorvastatin and calcineurin inhibitors: no interactions with tacrolimus.
2005,
Pubmed
Leonhardt,
Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters.
2010,
Pubmed
Maeda,
Identification of the rate-determining process in the hepatic clearance of atorvastatin in a clinical cassette microdosing study.
2011,
Pubmed
Müller,
Molecular aspects of hepatobiliary transport.
1997,
Pubmed
Neuvonen,
Drug interactions with lipid-lowering drugs: mechanisms and clinical relevance.
2006,
Pubmed
Noé,
Substrate-dependent drug-drug interactions between gemfibrozil, fluvastatin and other organic anion-transporting peptide (OATP) substrates on OATP1B1, OATP2B1, and OATP1B3.
2007,
Pubmed
Nozawa,
Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human.
2004,
Pubmed
Pan,
Interaction of Ethambutol with human organic cation transporters of the SLC22 family indicates potential for drug-drug interactions during antituberculosis therapy.
2013,
Pubmed
Peloquin,
Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids.
1999,
Pubmed
Pichichero,
Pharmacodynamic analysis and clinical trial of amoxicillin sprinkle administered once daily for 7 days compared to penicillin V potassium administered four times daily for 10 days in the treatment of tonsillopharyngitis due to Streptococcus pyogenes in children.
2008,
Pubmed
Puri,
Roxithromycin: a pharmacokinetic review of a macrolide.
1987,
Pubmed
Satoh,
Citrus juices inhibit the function of human organic anion-transporting polypeptide OATP-B.
2005,
Pubmed
Seki,
Contribution of organic anion transporting polypeptide OATP2B1 to amiodarone accumulation in lung epithelial cells.
2009,
Pubmed
Shin,
Peripheral neuropathy associated with treatment for multidrug-resistant tuberculosis.
2003,
Pubmed
Shitara,
Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs.
2005,
Pubmed
Stone,
Acute diffuse interstitial nephritis related to chemotherapy of tuberculosis.
1976,
Pubmed
Suzuki,
Transport of drugs across the hepatic sinusoidal membrane: sinusoidal drug influx and efflux in the liver.
2000,
Pubmed
Takeda,
Role of organic anion transporter 1 (OAT1) in cephaloridine (CER)-induced nephrotoxicity.
1999,
Pubmed
Tanuma,
Pharmacokinetics of rifabutin in Japanese HIV-infected patients with or without antiretroviral therapy.
2013,
Pubmed
Tirona,
Human organic anion transporting polypeptide-C (SLC21A6) is a major determinant of rifampin-mediated pregnane X receptor activation.
2003,
Pubmed
Tod,
Population pharmacokinetic study of amikacin administered once or twice daily to febrile, severely neutropenic adults.
1998,
Pubmed
Vaidyanathan,
Pharmacokinetics of the oral direct renin inhibitor aliskiren in combination with digoxin, atorvastatin, and ketoconazole in healthy subjects: the role of P-glycoprotein in the disposition of aliskiren.
2008,
Pubmed
Vavricka,
Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver.
2002,
Pubmed
,
Xenbase
WAY,
The absorption, distribution, excretion and fate of para-aminosalicylic acid.
1948,
Pubmed
Zhu,
Population pharmacokinetics of intravenous and intramuscular streptomycin in patients with tuberculosis.
2001,
Pubmed
